Background: Cardiovascular tissues express heme oxygenase (HO), which metabolizes heme to form carbon monoxide (CO). Carbon monoxide promotes relaxation of coronary vascular smooth muscle. Increased HO-1 expression provides cardioprotection during certain pathologic conditions. On a high salt (HS) diet Dahl salt-sensitive (DS) rats develop hypertension that is accompanied by left ventricular hypertrophy, whereas Dahl salt-resistant rats (DR) do not. This study tests the hypothesis that cardiac HO-1 expression is increased in DS rats with salt-induced hypertension and provides cardioprotection by promoting coronary vasodilation. Methods: Male DS and DR rats were placed on a HS (8% NaCl) or low salt (LS, 0.3% NaCl) diet for 4 weeks. Cardiac HO isoform expression were determined by immunohistochemistry. Experiments used isolated paced Langendorff-hearts perfused at a constant flow. Changes in coronary perfusion pressure and left ventricular contractility (dP/dt max ) were measured in response to an inhibitor of HO, chromium mesoporphyrin (CrMP).
H
eme oxygenase (HO) catalyzed degradation of heme is the major endogenous source of carbon monoxide (CO) production. 1 Numerous tissues, 2 including vascular endothelial and smooth muscle cells, 3, 4 express HO. The two major active isoforms of HO 2 are the inducible HO-1 (heat shock protein 32) and the constitutive HO-2. Pathologic conditions, 2 such as cardiac ischemia/reperfusion 5, 6 and angiotensin II-induced hypertension, 7 can increase cardiac HO-1 expression. The HO converts heme to biliverdin, iron, and CO. 1 Biliverdin is rapidly reduced to bilirubin, which is the primary antioxidant of the body. 8 Emerging evidence suggests that endogenously formed CO participates in the regulation of cardiovascular functions. 8, 9 Carbon monoxide inhibits vascular smooth muscle cell growth 10 and apoptosis, 11 relaxes vascular smooth muscle [12] [13] [14] and promotes coronary vasodilation in the isolated perfused heart. 15, 16 Numerous studies suggest that increased cardiac expression of HO-1 provides cardioprotection during pathologic conditions such as ischemia/reperfusion 5, 6, 17 or hypertension. 18 The Dahl/Rapp salt-sensitive (DS) rat is a genetic model of salt-sensitive hypertension. 19 On a high salt diet these animals rapidly develop hypertension, 19 which is associated with left ventricular hypertrophy 20, 21 that can eventually lead to myocardial failure. 21 We have shown that peripheral vascular HO-1 expression and endogenous CO production is increased in DS rats with salt-induced hypertension, whereas the high salt diet has no effect in the Dahl/Rapp salt-resistant (DR) rats. 22 On the basis of these findings we hypothesized that cardiac HO-1 expression is increased in DS rats with salt-induced hypertension and provides cardioprotection by promoting coronary vasodilation. To test this hypothesis we conducted experiments using hearts isolated from DS and DR rats after 4 weeks of high or low salt diets. We examined coronary expression of HO isoforms using immunohistochemistry and studied the effects of an inhibitor of HO on coronary perfusion pressure in isolated Langendorff-hearts perfused at a constant flow rate.
Methods

Chemicals
Chromium mesoporphyrin (CrMP) was from Frontier Scientific (Logan, UT). Inactin (thiobutabarbital sodium) was from Sigma-Aldrich (St. Louis, MO). Vectastain Elite ABC kit used for immunohistochemistry was from Vector Laboratories (Burlingame, CA). Polyclonal antibodies against HO-1 and HO-2 were obtained from StressGen Biotechnologies (Victoria, BC, Canada). All other chemicals were purchased from Fisher Scientific (Houston, TX). The CrMP stock solution (15 mmol/L) was prepared in 50 mmol/L Na 2 CO 3 solution followed by dilution in modified Krebs' buffer (15 mol/L) immediately before use. The composition of modified Krebs' buffer used from Langendorff-heart experiments was: NaCl 118. 
Animals
Male inbred Dahl/Rapp salt-sensitive (SS/Jr) rats (DS, n ϭ 34) and Dahl/Rapp salt-resistant (SR/Jr) rats (DR, n ϭ 17) were purchased at 5 to 6 weeks of age from Harlan (Indianapolis, IN). Before the experiments, rats were housed in a controlled environment and had free access to high (HS, 8.0% NaCl) or low (LS, 0.3% NaCl) salt diets (Dyets, Inc., Bethlehem, PA) and tap water for 4 weeks. All procedures were approved by the institutional animal care committee.
Blood Pressure Measurements and Heart Extractions
On the day of the experiment rats were anesthetized (Inactin, 100 mg/kg intraperitoneally) and a tracheal tube was inserted to facilitate breathing. A carotid arterial catheter (PE-50) was implanted for acute determination of blood pressure (BP) and heart rate. The arterial catheter was connected to a pressure transducer (TSD104A, Biopac Systems, Santa Barbara, CA) coupled to a polygraph system (MP100, Biopac Systems). After stable readings animals were heparinized (1000 U/kg intravenously), the heart was removed and placed into ice-cold modified Krebs' buffer.
HO Immunohistochemistry
Hearts were fixed (10% buffered formalin overnight, 4°C), embedded in paraffin and sectioned (4 to 5 m). Immunohistochemical staining for HO-1 and HO-2 was performed by using the avidin-biotin method as previously detailed. 23 The presence of HO-1 and HO-2 immunoreactivity was indicated by the development of a brown color.
Langendorff-Heart Experiments
Hearts were mounted on an aortic cannula to achieve coronary perfusion with heated (37°C, Isotemp 2100, Fisher Scientific, Houston, TX) oxygenated (95% O 2 and 5% CO 2 , Air Liquide, Harvey, LA) modified Krebs' buffer at constant flow rate (Masterflex pump, Cole-Parmer, Vernon Hills, IL). Coronary perfusion pressure and flow were measured by an inline pressure transducer (TSD104A, Biopac Systems Inc.) and an inline flow probe (1NRB2512, Transonic Systems Inc., Ithaca, NY) connected to a flow meter (T206, Transonic Systems), respectively. A balloon filled with distilled water connected to a pressure transducer was inserted into the left ventricle. The flow meter and the pressure transducers were coupled to a computerized polygraph system (MP100, Biopac Systems Inc.). Two electrodes coupled to a stimulator (Physiograph SI-10, E & M Instrument Co., Inc., Houston, TX) were inserted close to the ventricular septum and hearts were paced at a constant rate10% above their spontaneous heart rates. After a stabilization period (60 to 90 min) an inhibitor of HO, 15 mol/L CrMP, or matched vehicle was included into the perfusate for 45 min. After the experimental protocols were completed, coronary resistances were calculated as the pressure-to-flow ratio and expressed as mm Hg/mL min. As an index of myocardial contractility, the first derivative of the left ventricular pressure was calculated as the maximal change in pressure-to-time ratio (dP/dt max ) and expressed as mm Hg/sec.
Statistics
All data are expressed as mean Ϯ S.E.M. Langendorffheart data were analyzed by analysis of variance (ANOVA) using a statistical package (SYSTAT, SYSTAT software Inc., Richmond, CA). When significant differences were observed, orthogonal contrasts were performed as a post-hoc analysis. 24 All other data were analyzed by t tests. P Ͻ .05 was considered statistically significant.
Results
Findings in DS Strain
In DS animals, 4 weeks of HS diet (Table 1) significantly increased the arterial pressures, but had no significant effect on the heart rate. After 4 weeks of diets, heart weights ( Table 1) and heart-to-body weight ratios were higher in the HS group.
The HO-1 immunostaining of the left coronary artery (Fig. 1 ) was enhanced in vascular smooth muscle and in the endothelium of DS animals placed on 4 weeks of HS diet. The HO-2 immunostaining was apparent both in the smooth muscle and in the endothelium, but was not appreciably affected by the HS diet.
Hearts extracted (Fig. 2 ) from HS diet animals exhibited a higher pressure and calculated coronary resistance when perfused at a constant flow of 4.0 Ϯ 0.1 mL/min (P Ͻ .05 LS v HS). Treatment with the HO inhibitor, 15 mol/L CrMP, increased the perfusion pressures in LS animal hearts (102 Ϯ 2 and 116 Ϯ 5 mm Hg, before and 45 min after; n ϭ 5; P Ͻ .05), but the CrMP response was exaggerated (P Ͻ .05 HS v LS) in hearts taken from the HS diet animals (115 Ϯ 6 and 187 Ϯ 8 mm Hg, before and 45 min after; n ϭ 7; P Ͻ .05). Similarly, treatment with CrMP increased calculated coronary resistances in LS animal hearts (26 Ϯ 3 and 33 Ϯ 4 mm Hg/mL min), before and 45 min after; n ϭ 5; P Ͻ .05), but the CrMP response was exaggerated (P Ͻ .05 HS v LS) in those taken from the HS diet animals (33 Ϯ 6 and 51 Ϯ 9 mm Hg/mL min), before and 45 min after; n ϭ 7; P Ͻ .05). The CrMPinduced increases in resistance were accompanied by a faster decrease in cardiac contractility (Fig. 3) in the HS (756 Ϯ 180; 621 Ϯ115, and 642 Ϯ 132 mm Hg/sec, before, 10, and 45 min after; n ϭ 7; P Ͻ .05) than in the LS groups (807 Ϯ 68; 703 Ϯ 40, and 652 Ϯ 34 mm Hg/sec, before, 10, and 45min after; n ϭ 5; P Ͻ .05).
Findings in DR Strain
In complementary experiments using DR animals, 4 weeks of HS diet (Table 1 ) had no effect on arterial pressures or 
FIG. 1.
Immunohistochemical staining of heme oxygenase-2 (HO-2) (panels B and E) and heme oxygenase-1 (HO-1) (panels C and F) in coronary arteries isolated from DS rats after 4 weeks of low (top panels) or high (bottom panels) salt diets. Control sections with primary antibody omitted (panels A and D). Hematoxylin background staining (blue). Brown color indicates the presence of immunoreactivity.
Identical ϫ40 magnification on all panels.
heart rates. After 4 weeks of diets, neither the heart weights (Table 1) nor the heart-to-body weight ratios were different. In addition, LS and HS animals showed no differences in either HO-1 or HO-2 immunostaining of the left coronary artery (images not shown). In contrast to our findings with the DS animals, DR hearts required a flow of 14.0 Ϯ 1.0 mL/min to maintain a stable preparation. The LS (n ϭ 5) and HS (n ϭ 6) hearts extracted from the DR animals ( Fig. 2) yielded similar perfusion pressures (128 Ϯ 3 and 126 Ϯ 6 mm Hg, LS and HS), and calculated coronary resistances (9.3 Ϯ 0.5 and 8.7 Ϯ 1.0 mm Hg/mL min, LS and HS). Treatment with the HO inhibitor, 15 mol/L CrMP, similarly increased the perfusion pressures in LS and HS animal hearts (135 Ϯ 4 and 144 Ϯ 6mmHg, respectively) and corresponding increases in the calculated coronary resistances (9.9 Ϯ 0.5 and 9.5 Ϯ 0.1 mm Hg/mL min) at 45 min. In LS hearts, CrMP-induced increases in resistance were accompanied by decreases (P Ͻ .05) in cardiac contractility (1906 Ϯ 115, 1683 Ϯ 259, and 1642 Ϯ 233 mm Hg/sec; before, 10, and 45 min after; P Ͻ .05), which were similar to those measured in the HS group (2119 Ϯ 213, 1782 Ϯ 311, and 1759 Ϯ 271 mm Hg/sec; before, 10, and 45 min after).
Discussion
In this study we found that coronary vascular HO-1 expression was increased in DS rats with salt-induced hypertension. Hearts taken from the DS salt-hypertensive animals displayed increased vasoconstrictor responsiveness to an inhibitor of HO. These data suggest that increased coronary HO-1 expression may provide cardioprotection during DS hypertension by promoting coronary vasodilation.
FIG. 2.
Effects of a heme oxygenase inhibitor, chromium mesoporphyrin (CrCP, 15 mol/L), on heart rate (top), coronary perfusion pressure (upper middle), coronary flow (lower middle), and calculated coronary resistance (bottom) in Langendorff-perfused hearts isolated from Dahl salt-sensitive (left panel) and Dahl salt-resistant (right panel) rats after 4 weeks of low salt (open circles, n ϭ 5 and n ϭ 5, respectively) or high salt diet (closed circles, n ϭ 7 and n ϭ 6, respectively). Data are expressed as mean Ϯ SEM. *P Ͻ .05 high salt v low salt.
FIG. 3.
Effects of a heme oxygenase inhibitor, chromium mesoporphyrin (CrMP, 15 mol/L), on left ventricular contractility (dP/dt max ) in Langendorff-perfused hearts isolated from Dahl salt-sensitive rats after 4 weeks of low salt (open bars, n ϭ 5) or high salt diet (closed bars, n ϭ 7). Data are expressed as mean Ϯ SEM. *P Ͻ .05 high salt v low salt.
The DS rat is a genetic model of salt-induced hypertension. We found that after 4 weeks, DS rats on the HS diet had higher mean arterial pressures than LS diet controls. This salt-induced hypertension in DS rats was accompanied by higher heart weight and increased heart-tobody weight ratio compared to LS controls. These data suggest that 4 weeks of salt-induced hypertension in DS rats is accompanied by cardiac enlargement consistent with cardiac hypertrophy in this model. 20, 21 The major endogenous source of CO production is the HO-catalyzed enzymatic degradation of heme.
1 Numerous tissues, 2 including vascular endothelial and smooth muscle cells 3, 4 express HO. To date, three HO isoforms have been described. 2, 25 The HO-1 (heat shock protein 32) is the inducible isoform, because its gene expression can be increased severalfold by various stimuli. 2 The HO-2 is regarded as the constitutive isoform, because its expression is relatively constant. 2 Little is known about HO-3 except that it has negligible catalytic activity compared to the other two isoforms. 25 Previous studies 7 suggested that angiotensin II-induced hypertension increases cardiac expression of HO-1.Our current data show that coronary arteries of hearts isolated from DS rats after 4 weeks of HS diet display enhanced immunostaining for HO-1 compared to the LS group. In contrast, HO-2 staining was similar in both groups. These data suggest that salt-induced hypertension in DS rats is accompanied by increased coronary HO-1 protein content that may contribute to the increased endogenous CO production.
Increased cardiac HO-1 expression has been reported to confer cardioprotection during various pathological conditions, 5, 6, 17, 18 and CO has been shown to promote coronary vasodilation in isolated perfused hearts. 15, 16 In the current study we found that hearts isolated from HS diet animals exhibited a higher pressure and calculated coronary resistance when perfused at a constant flow. The CrMP is a potent inhibitor of HO, which has been shown to promote vasoconstriction in isolated skeletal muscle arterioles. 23 Treatment with CrMP increased the perfusion pressure and calculated coronary resistance in LS animal hearts, but the CrMP response was exaggerated in those taken from the HS diet animals. The CrMP-induced increases in resistance were accompanied by a decrease in cardiac contractility in both groups. These data suggest that increased endogenous HO activity promotes coronary vasodilation during salt-induced hypertension in DS rats.
The DR rats are resistant to the hypertensive effects of HS diet and are commonly accepted controls for the DS strain. 19 To assess if HS diet alone, in the absence of hypertension and genetic salt sensitivity, can induce the changes we have seen in DS rats, we conducted complementary experiments in DR rats. In agreement with other investigators 19, 20 and our previous studies, 22 we found that DR rats on HS diets did not develop hypertension or cardiac hypertrophy. Similar to our previous results, 22 we did not find any changes in HO-1 levels between HS and LS diet animals. Furthermore, in Langendorff-perfused hearts isolated from DR rats the HO inhibitor CrMP elicited similar responses. These data suggest that the enhanced coronary HO-1 immunostaining and CrMPinduced vasoconstriction in DS rats on HS diets is not an effect of the HS diet per se, but rather due to the combination of HS diet, hypertension or genetic salt sensitivity.
In summary, our data shows that after 4 weeks of HS diet DS rats display hypertension and cardiac enlargement consistent with hypertrophy. Hypertensive DS rats show enhanced coronary arterial immunostaining for HO-1. Furthermore, hearts isolated from DS rats on HS diet show enhanced coronary vasoconstriction in response to a HO inhibitor. These data suggest that increased coronary arterial HO-1 expression during salt-induced hypertension in DS rats confers cardioprotection by promoting coronary vasodilation perhaps through enhanced generation of CO.
